Mark S. Levine Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark S. Levine.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark S. Levine. Mark S. Levine is a General Counsel in Flexion Therapeutics Inc ($FLXN) and a SVP & General Counsel in Flexion Therapeutics Inc ($FLXN) and a SVP,General Counsel & Sec. in Minerva Neurosciences, Inc. ($NERV) and a VP,General Counsel & Sec. in Minerva Neurosciences, Inc. ($NERV).

Address: C/O MINERVA NEUROSCIENCES, INC. 245 FIRST STREET SUITE 1800 CAMBRIDGE 02142 MA

Companies in which Mark S. Levine is an Insider

Flexion Therapeutics Inc

Trading Symbol: FLXN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark S. Levine: SVP & General Counsel
Holdings: 107,431 shares
Current Value: $2,045,486
Latest Transaction: Jan 07 2021
$FLXN Market Capitalization: $504.85M
$FLXN Previous Close: $19.04

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 2x
Shares Bought: 124,608
Shares Sold: 10,553
Share Difference: +114,055
Value Difference: +$41,591

Minerva Neurosciences, Inc.

Trading Symbol: NERV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark S. Levine: SVP,General Counsel & Sec., VP,General Counsel & Sec.
Holdings: 17,500 shares
Current Value: $177,625
Latest Transaction: Jun 05 2017
$NERV Market Capitalization: $346.33M
$NERV Previous Close: $10.15

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 35,000
Shares Sold: 35,000
Share Difference: 0
Value Difference: +$229,130

Latest Insider Trading Transactions of Mark S. Levine

Sentiment: All, FLXN, NERV

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 07 2021FLXNFlexion Therapeuti ...Levine Mark S.General CounselSellS11.136,82976,007107,431114.3 K to 107.4 K (-5.98 %)
Jul 20 2020FLXNFlexion Therapeuti ...Levine Mark S.General CounselGrantA0.0038,7500114,26075.5 K to 114.3 K (+51.32 %)
Jul 20 2020FLXNFlexion Therapeuti ...Levine Mark S.General CounselGrantA0.0038,7500114,26075.5 K to 114.3 K (+51.32 %)
Jun 24 2020FLXNFlexion Therapeuti ...Levine Mark S.General CounselGrantA10.831,02311,07975,51074.5 K to 75.5 K (+1.37 %)
Jan 07 2020FLXNFlexion Therapeuti ...Levine Mark S.General CounselSellS0.003,724043,48747.2 K to 43.5 K (-7.89 %)
Jun 24 2019FLXNFlexion Therapeuti ...Levine Mark S.General CounselGrantA9.811,21311,90046,27345.1 K to 46.3 K (+2.69 %)
Mar 05 2019FLXNFlexion Therapeuti ...Levine Mark S.General CounselOption ExerciseA14.7518,000265,50018,000

View all Mark S. Levine insider transactions.